- Pagina principale
- Analisi delle app
- Multiple Myeloma Management
- Multiple Myeloma Management Vs. Multiple Myeloma [MM]
Multiple Myeloma Management vs. Multiple Myeloma [MM] Utilizzo e statistiche
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Multiple Myeloma @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Multiple Myeloma content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
Multiple Myeloma ManagementRanking a confronto con Multiple Myeloma [MM]
Confronta la tendenza di classifica Multiple Myeloma Management nei ultimi 28 giorni rispetto a Multiple Myeloma [MM]
Rank
Nessun dato disponibile
Classifica Multiple Myeloma Management vs. Multiple Myeloma [MM] per paese a confronto
Confronta la tendenza di classifica Multiple Myeloma Management nei ultimi 28 giorni rispetto a Multiple Myeloma [MM]
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
Multiple Myeloma Management VS.
Multiple Myeloma [MM]
19icembre d, 2024